A detailed history of Capital Advisors, Ltd. LLC transactions in Cerus Corp stock. As of the latest transaction made, Capital Advisors, Ltd. LLC holds 484 shares of CERS stock, worth $803. This represents 0.0% of its overall portfolio holdings.

Number of Shares
484
Previous 484 -0.0%
Holding current value
$803
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

SELL
$1.25 - $2.35 $355 - $667
-284 Reduced 36.98%
484 $1,000
Q3 2023

Oct 27, 2023

BUY
$1.5 - $3.07 $1,152 - $2,357
768 New
768 $1,000

Others Institutions Holding CERS

About CERUS CORP


  • Ticker CERS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 177,090,000
  • Market Cap $294M
  • Description
  • Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...
More about CERS
Track This Portfolio

Track Capital Advisors, Ltd. LLC Portfolio

Follow Capital Advisors, Ltd. LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.